TY - JOUR
T1 - Cervical cancer screening
AU - León-Maldonado, Leith
AU - López-Olmedo, Nancy
AU - Murillo, Raúl
AU - Hurtado-Salgado, Erika
AU - Allen-Leigh, Betania
AU - Armengol-Alonso, Alejandra
AU - Torres-Mejía, Gabriela
AU - Bautista-Arredondo, Sergio
AU - Barrientos-Gutiérrez, Tonatiuh
AU - Lazcano-Ponce, Eduardo
N1 - Publisher Copyright:
© (2023), (Instituto Nacional de Salud Publica). All Rights Reserved.
PY - 2024
Y1 - 2024
N2 - Objective. To estimate the prevalence of Papanicolaou (Pap) and human papillomavirus (HPV) test use before and after the SARS-CoV-2 pandemic. Materials and methods. We analyzed the use of Pap and/or HPV screening tests by women 25-64 years, using data from the National Health and Nutrition Surveys in 2018 and 2021-2023. Results. Pap use decreased from 34.6% in 2018 to 24.9% in 2021, recovering to 31.5% in 2023. Similarly, HPV use decreased from 12.7% in 2018 to 11% in 2021, increasing to 16.0% in 2023. Greater use of cervical cancer screening was observed at higher socioeconomic levels and urbanization. Conclusions. Improved regulatory guidelines are needed to achieve efficient and effective screening and follow-up of cervical cancer in Mexico.
AB - Objective. To estimate the prevalence of Papanicolaou (Pap) and human papillomavirus (HPV) test use before and after the SARS-CoV-2 pandemic. Materials and methods. We analyzed the use of Pap and/or HPV screening tests by women 25-64 years, using data from the National Health and Nutrition Surveys in 2018 and 2021-2023. Results. Pap use decreased from 34.6% in 2018 to 24.9% in 2021, recovering to 31.5% in 2023. Similarly, HPV use decreased from 12.7% in 2018 to 11% in 2021, increasing to 16.0% in 2023. Greater use of cervical cancer screening was observed at higher socioeconomic levels and urbanization. Conclusions. Improved regulatory guidelines are needed to achieve efficient and effective screening and follow-up of cervical cancer in Mexico.
KW - human papillomavirus DNA tests
KW - papanicolaou
KW - prevalence
KW - screening
KW - uterine cervical neoplasms
UR - https://www.scopus.com/pages/publications/85202775215
U2 - 10.21149/15894
DO - 10.21149/15894
M3 - Article
AN - SCOPUS:85202775215
SN - 0036-3634
VL - 66
SP - 549
EP - 555
JO - Salud Publica de Mexico
JF - Salud Publica de Mexico
IS - 4
ER -
